Boston awaits
Registration is opening soon for the ACAAI 2024 Annual Scientific Meeting, Oct. 24-28 in Boston. You’ll get more in 2024!
Don’t take a vacation from promoting your practice
Your practice promotions can heat up this summer as temperatures rise. Now is a great time to promote your services as an allergist.
Nominate a FIT for a 2024 Annals Award
Fellows-in-Training who publish the best article (original research or review) in Annals will receive a cash award.
JTFPP is accepting nominations
The JTFPP is currently accepting nominations for one ACAAI position with a term that will begin in July 2025.
ACAAI-endorsed prior authorization legislation reintroduced
On June 12, the Improving Seniors’ Timely Access to Care Act was reintroduced in both the House and Senate.
Legacy of Congressman George Miller O’Brien: Advocate for the Patient with Asthma and Allergic Disease
Mr. O’Brien had a deep-rooted commitment to the support of research in the field of allergic diseases, and helped to establish CIRIDs.
The latest government threat to access: Prescription Drug Affordability Boards
As PDABs focus only on price, may not assess value the same way you and your patients do, and aren’t concerned with improving patient care.
June issue focuses on the relationship between atopic dermatitis and food allergy
The June issue is the last issue of Annals' 80th year of publication – and it is a great issue for you to read!
ACAAI position paper looks at use of live vaccines for patients on dupilumab
ACAAI has released a position paper regarding the safety of administering live vaccines to patients currently being treated with dupilumab.
… results.
